Solid Tumour Standard Treatments
Type of Cancer |
First Line |
Second Line |
| Non-Small Cell Lung Cancer (NSCLC) | Carboplatin / Taxol | Alimta |
| Small Cell Lung Cancer (SCLC) | Carboplatin / Etopophos | Cyclophosphamide / Adriamycin / Vincristine |
| Melanoma | DTIC / Fotemustine | Cisplatin |
| Early Colorectal Cancer | FOLFOX / Capecitabine | |
| Metastatic Colorectal Cancer | FOLFOX (modified 46hr infusion 5-FU) | FOLFIRI |
| Early Prostate Cancer | Docetaxel & Prednisone | Mitozantrone |
| Hormone Refractory Metastatic Prostate Cancer | Docetaxel & Prednisone | Mitozantrone |
| Early Breast Cancer | Multiple options | |
| Metastatic Breast Cancer | AC / Hormonal Therapy | Multiple Options |
| Metastatic Transitional Cell Carcinoma of the Bladder |
Cisplatin / Gemcitabine | |
| Mesothelioma | Cisplatin / Alimta | |
| Metastatic Renal Cell Carcinoma | Sunitinib | |
| Metastatic Hepatocellular Carcinoma | Sorafenib | |
| Metastatic Gastroesophageal Adenocarcinoma | ECF | |
| Metastatic Pancreatic Cancer | Gemcitabine | |
| Ovarian Cancer | Carboplain / Paclitaxel | Multiple Options |
| Endometrial Cancer | Cisplatin / Adriamycin | Provera |
| Head and Neck Squamous Cell Carcinoma | Cisplatin / 5-FU | Methotrexate |
Haematological Standard Treatments
Type of Cancer |
First Line |
Second Line |
| Non-Hodgkin’s Lymphoma (NHL) | R-CHOP R-CVP |
RICE |
| Hodgkin’s Lymphoma | ABVD, BEACOPP14 |
RICE |
| Chronic Lymphocyctic Leukaemia | FC FCR Chlorambucil |
FC FCR |
| Small Lymphocytic Leukaemia | FC FCR Chlorambucil |
FC FCR |
| Mulitple Myeloma | CID MP |
Thalidomide / Dexamethasone |
| Idiopathic Thrombocytopaenic Purpura | Prednisone | Intragam |